首页> 外文期刊>Journal of Leukocyte Biology: An Official Publication of the Reticuloendothelial Society >The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation.
【24h】

The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation.

机译:β-血球蛋白和血小板因子4:血小板衍生的CXC趋化因子在中性粒细胞的早期调节中具有不同的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The recruitment of neutrophil granulocytes to sites of tissue injury is one of the earliest events during host defense. Several chemotactic cytokines belonging to the CXC subfamily of chemokines are thought to be implicated in this kind of response. Especially those CXC chemokines that are stored in blood platelets and become immediately released upon activation are likely to dominate neutrophil-dependent host defense at the onset of inflammation. The major platelet-derived CXC chemokines are the beta-thromboglobulins and platelet factor 4 (PF-4), which are both released into the blood at micromolar concentrations. The availability as well as the functional activity of these mediators appear to be subject to tight control by diverse regulatory mechanisms. These include proteolytic processing of chemokine precursors, oligomer formation, and the differential usage of neutrophil-expressed receptors. Herein we review our work on early neutrophil regulation by PF-4, the beta-thromboglobulin neutrophil-activating peptide 2 (NAP-2) and its major precursor connective tissue-activating peptide III (CTAP-III). We moreover propose a model to assess the contribution by either of these chemokines to coordinated recruitment and activation of neutrophils in response to acute tissue injury.
机译:将中性粒细胞粒细胞募集到组织损伤部位是宿主防御过程中最早的事件之一。属于趋化因子CXC亚家族的几种趋化细胞因子被认为与这种反应有关。尤其是那些储存在血小板中并在激活后立即释放的CXC趋化因子,很可能在炎症发作时主导中性粒细胞依赖性宿主防御。血小板衍生的主要CXC趋化因子是β-血球蛋白和血小板因子4(PF-4),它们均以微摩尔浓度释放到血液中。这些介体的可用性和功能活性似乎受到各种监管机制的严格控制。这些包括趋化因子前体的蛋白水解处理,低聚物形成以及嗜中性粒细胞表达受体的差异使用。在本文中,我们回顾了我们对PF-4,β-血球蛋白嗜中性粒细胞激活肽2(NAP-2)及其主要前体结缔组织激活肽III(CTAP-III)的早期嗜中性粒细胞调节的研究。此外,我们提出了一种模型来评估这些趋化因子对响应急性组织损伤的中性粒细胞的协同募集和活化的贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号